Pharmacotherapies for alcohol problems: a review of research with focus on developments since 1991. (Q41159382)

27 September 2017

1 reference

title

Pharmacotherapies for alcohol problems: a review of research with focus on developments since 1991. (English)

1 reference

27 September 2017

0 references

R Z Litten

1

1 reference

27 September 2017

J Allen

series ordinal

2

1 reference

27 September 2017

J Fertig

series ordinal

3

1 reference

27 September 2017

language of work or name

1 reference

1 August 1996

1 reference

Alcoholism: Clinical and Experimental Research

27 September 2017

published in

1 reference

27 September 2017

volume

20

1 reference

27 September 2017

issue

5

1 reference

27 September 2017

page(s)

859-876

1 reference

Pharmacotherapies for alcoholism: promising agents and clinical issues

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Detoxification of alcoholics: improving care by symptom-triggered sedation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Alcohol detoxification and withdrawal seizures: clinical support for a kindling hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Diazepam prevents progression of kindled alcohol withdrawal behaviour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Management of the alcohol withdrawal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Double-blind study of alprazolam, diazepam, clonidine, and placebo in the alcohol withdrawal syndrome: preliminary findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Bart's syndrome: microscopic, ultrastructural, and immunofluorescent mapping features

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Antagonism of ethanol withdrawal convulsions in Withdrawal Seizure Prone mice by diazepam and abecarnil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Effects of nitrendipine, chlordiazepoxide, flumazenil and baclofen on the increased anxiety resulting from alcohol withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

The glutamatergic basis of human alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Ethanol and the NMDA receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Ethanol withdrawal seizures and the NMDA receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Mapping rat brain structures activated during ethanol withdrawal: role of glutamate and NMDA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Circadian variation in plasma homovanillic acid level during and after alcohol withdrawal in alcoholic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Acute withdrawal after repeated ethanol treatment reduces the number of spontaneously active dopaminergic neurons in the ventral tegmental area

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats: electrophysiological and biochemical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

New medical review series--4. Alcohol intoxication and physical dependence: a molecular mystery tour

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

CRF antagonist reverses the "anxiogenic" response to ethanol withdrawal in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Application of a synthetic analogue of leu-enkephalin (Dalargin) in alcohol withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Opiates in ethanol withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Role of gangliosides in behavioral and biochemical actions of alcohol: cell membrane structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Ability of calcium bis acetyl homotaurine, a GABA agonist, to prevent relapse in weaned alcoholics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Naltrexone in the treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Six-month follow-up of naltrexone and psychotherapy for alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Naltrexone-induced alterations in human ethanol intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Opioid involvement in alcohol drinking

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

The delta 2-opioid receptor antagonist naltriben selectively attenuates alcohol intake in rats bred for alcohol preference

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Lack of effects of Ca-acetyl homotaurinate on chronic and acute toxicities of ethanol in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Acamprosate modulates synaptosomal GABA transmission in chronically alcoholised rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Acamprosate (calciumacetylhomotaurinate) decreases postsynaptic potentials in the rat neocortex: possible involvement of excitatory amino acid receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Fluvoxamine treatment of alcoholic amnestic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Specific decreases in ethanol- but not water-reinforced responding produced by the 5-HT3 antagonist ICS 205-930.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Antagonism of 5-HT3 receptors attenuates the effects of ethanol on extracellular dopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Attenuation of some alcohol-induced mood changes and the desire to drink by 5-HT3 receptor blockade: a preliminary study in healthy male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Clinical efficacy of the 5-HT3 antagonist ondansetron in alcohol abuse and dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Long-lasting suppression of alcohol preference in rats following serotonin receptor blockade by ritanserin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

The increased ethanol preference in rats induced by choice, darkness, or drugs is reduced by ritanserin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

5-HT2 receptor blockade by amperozide suppresses ethanol drinking in genetically preferring rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Suppression of alcohol preference in high alcohol drinking rats: efficacy of amperozide versus naltrexone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Ritanserin, a central 5-HT2 antagonist, in heavy social drinkers: desire to drink, alcohol intake and related effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Single-dose ritanserin and alcohol in healthy volunteers: a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Treatment of alcohol and cocaine addiction by the combination of pemoline and fenfluramine: a preliminary case series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Involvement of the serotonergic system in ethanol intake in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Low doses of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH DPAT) increase ethanol intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

The 5-HT4 receptor antagonist, GR113808, reduces ethanol intake in alcohol-preferring rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Ro15-4513 attenuates the consumption of ethanol in deprived rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Ethanol Self‐Administration in Deprived Rats: Effects of Ro15‐4513 Alone, and in Combination with Flumazenil (Ro15‐1788)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

GABA antagonist and benzodiazepine partial inverse agonist reduce motivated responding for ethanol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Ro 15-4513 selectively attenuates ethanol, but not sucrose, reinforced responding in a concurrent access procedure; comparison to other drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

gamma-Hydroxybutyric acid in the treatment of alcohol dependence: a double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Drugs of abuse: anatomy, pharmacology and function of reward pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Effects of dopaminergic agents on alcohol consumption by rats in a limited access paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Oral ethanol self-administration in rats is reduced by the administration of dopamine and glutamate receptor antagonists into the nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Effect of dopamine agonists and antagonists on ethanol-reinforced behavior: the involvement of the nucleus accumbens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Isradipine and other calcium channel antagonists attenuate ethanol consumption in ethanol-preferring rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

The effect of 3-amino-1,2,4-triazole on voluntary ethanol consumption: evidence for brain catalase involvement in the mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Bestatin, an aminopeptidase B inhibitor, selectively reduces alcohol intake in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Daidzin and daidzein suppress free-choice ethanol intake by Syrian golden hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Attenuation of alcohol intake by ibogaine in three strains of alcohol-preferring rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Cholecystokinin and bombesin inhibit ethanol and food intake in rats selectively bred for ethanol sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Techniques to enhance compliance with disulfiram

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

The use of calcium carbimide in relapse prevention counselling: results of a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Imipramine treatment of alcoholism with comorbid depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Comparison in humans of the potency and pharmacokinetics of intravenously injected cocaethylene and cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

A behavioral treatment of alcoholic methadone patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

The treatment of alcoholic methadone patients: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

NMDA antagonist inhibits rapid tolerance to ethanol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Differential inhibition by NMDA antagonists of rapid tolerance to, and cross-tolerance between, ethanol and chlordiazepoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Interaction between ethanol and calcium channel blockers in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

The influence of neurohypophysial hormones on central nervous system processes of adaptation: functional tolerance to ethanol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

GM1 ganglioside reduces ethanol intoxication and the development of ethanol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Dehydroepiandrosterone is an anxiolytic in mice on the plus maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Pregnenolone and pregnenolone sulfate, alone and with ethanol, in mice on the plus-maze

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

Neurosteroids block the memory-impairing effects of ethanol in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1996.TB05264.X

10.1111/J.1530-0277.1996.TB05264.X

21 January 2018

Identifiers

DOI

1 reference

27 September 2017

1 reference